| Source Date | Board Meeting Date | Details |
|
12-Apr-2024
|
16-May-2024
|
Audited Results & Final Dividend
|
|
10-Jan-2024
|
08-Feb-2024
|
Quarterly Results
|
|
09-Oct-2023
|
10-Nov-2023
|
Quarterly Results
|
|
21-Jul-2023
|
10-Aug-2023
|
Quarterly Results
|
|
24-Apr-2023
|
26-Apr-2023
|
Inter alia, to consider the issue of Secured, Redeemable, Non-Convertible Debentures on private placement basis, investment in securities to be issued by Biocon Biologics Limited and provision of guarantees/put options, amongst other matters.
|
|
20-Apr-2023
|
23-May-2023
|
Final Dividend & Audited Results & A.G.M.
|
|
06-Jan-2023
|
14-Feb-2023
|
Quarterly Results
|
|
20-Oct-2022
|
14-Nov-2022
|
Quarterly Results
|
|
01-Jul-2022
|
27-Jul-2022
|
Quarterly Results
|
|
04-Apr-2022
|
28-Apr-2022
|
Audited Results & Dividend
|
|
03-Jan-2022
|
20-Jan-2022
|
Quarterly Results
|
|
05-Oct-2021
|
21-Oct-2021
|
Quarterly Results
|
|
06-Jul-2021
|
22-Jul-2021
|
Quarterly Results
|
|
12-Apr-2021
|
28-Apr-2021
|
Final Dividend & Audited Results
|
|
05-Jan-2021
|
21-Jan-2021
|
Quarterly Results
|
|
06-Oct-2020
|
22-Oct-2020
|
Quarterly Results
|
|
07-Jul-2020
|
23-Jul-2020
|
Quarterly Results
|
|
22-Apr-2020
|
14-May-2020
|
Audited Results
|
|
03-Jan-2020
|
23-Jan-2020
|
Quarterly Results
|
|
03-Oct-2019
|
23-Oct-2019
|
BIOCON LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2019 ,inter alia, to consider and approve the un-audited standalone and consolidated financial results for the quarter and half year ended September 30, 2019 amongst other routine matters. The trading window for dealing in securities of the Company for all insiders, as defined under the Code of Conduct for Prevention of Insider Trading ('the Code') of the Company, has been closed from October 1, 2019 to October 25, 2019 (both days inclusive) in compliance with the provisions of the Code of the Company read with SEBI (Prohibition of Insider Trading) Regulations.
|